최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Theranostics, v.9 no.3, 2019년, pp.837 - 852
Kim, Min Woo (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , Jeong, Hwa Yeon (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , Kang, Seong Jae (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , Jeong, In Ho (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , Choi, Moon Jung (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , You, Young Myoung (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , Im, Chan Su (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) , Song, In Ho (Division of RI-Convergence Research, Korea Institute of Radiological and Medical Science, Seoul, Republic of Korea) , Lee, Tae Sup (Division of RI-Convergence Research, Korea Institute of Radiological and Medical Science, Seoul, Republic of Korea) , Lee, Jin Suk (Department of Anatomy, Yonsei University Wonju Collage of Medicine, Wonju, Republic of Korea) , Lee, Aeju (International Research Organizatio) , Park, Yong Serk
Many aptamers have been evaluated for their ability as drug delivery vehicles to target ligands, and a variety of small interfering RNAs (siRNAs) have been tested for their anti-cancer properties. However, since these two types of molecules have similar physicochemical properties, it has so far been...
1 Keefe AD Pai S Ellington A Aptamers as therapeutics Nat Rev Drug Discov 2010 9 537 50 20592747
2 Chen K Liu B Yu B Zhong W Lu Y Zhang J Advances in the development of aptamer drug conjugates for targeted drug delivery Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017 9
3 Hori SI Herrera A Rossi JJ Zhou J Current advances in aptamers for cancer diagnosis and therapy Cancers (Basel) 2018 10
4 Darmostuk M Rimpelova S Gbelcova H Ruml T Current approaches in SELEX: An update to aptamer selection technology Biotechnol Adv 2015 33 1141 61 25708387
5 Esposito CL Nuzzo S Kumar SA Rienzo A Lawrence CL Pallini R A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells J Control Release 2016 238 43 57 27448441
6 Wang T Gantier MP Xiang D Bean AG Bruce M Zhou SF EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model Theranostics 2015 5 1456 72 26681989
7 Catuogno S Rienzo A Di Vito A Esposito CL de Franciscis V Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates J Control Release 2015 210 147 59 25998051
8 Xiang D Shigdar S Qiao G Wang T Kouzani AZ Zhou SF Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Theranostics 2015 5 23 42 25553096
9 Elbashir SM Lendeckel W Tuschl T RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev 2001 15 188 200 11157775
10 Titze-de-Almeida R David C Titze-de-Almeida SS The race of 10 synthetic RNAi-based drugs to the pharmaceutical market Pharm Res 2017 34 1339 63 28389707
11 Barros SA Gollob JA Safety profile of RNAi nanomedicines Adv Drug Deliv Rev 2012 64 1730 7 22732527
12 Hu Y Duan J Zhan Q Wang F Lu X Yang XD Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro PLoS One 2012 7 e31970 22384115
13 Volkov AA Kruglova NS Meschaninova MI Venyaminova AG Zenkova MA Vlassov VV Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect Oligonucleotides 2009 19 191 202 19344210
14 Whitehead KA Langer R Anderson DG Knocking down barriers: advances in siRNA delivery Nat Rev Drug Discov 2009 8 129 38 19180106
15 Dass CR Choong PF Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability J Control Release 2006 113 155 63 16764960
16 Akbarzadeh A Rezaei-Sadabady R Davaran S Joo SW Zarghami N Hanifehpour Y Liposome: classification, preparation, and applications Nanoscale Res Lett 2013 8 102 23432972
17 Kim MW Jeong HY Kang SJ Choi MJ You YM Im CS Cancer-targeted nucleic acid delivery and quantum dot imaging using EGF receptor aptamer-conjugated lipid nanoparticles Sci Rep 2017 7 9474 28842588
18 Yip KW Reed JC Bcl-2 family proteins and cancer Oncogene 2008 27 6398 406 18955968
19 Kampfer S Windegger M Hochholdinger F Schwaiger W Pestell RG Baier G Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras J Biol Chem 2001 276 42834 42 11551901
20 Gunaratne A Thai BL Di Guglielmo GM Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor beta-induced epithelial-to-mesenchymal transition Mol Cell Biol 2013 33 874 86 23249950
21 Paul A Gunewardena S Stecklein SR Saha B Parelkar N Danley M PKClambda/iota signaling promotes triple-negative breast cancer growth and metastasis Cell Death Differ 2014 21 1469 81 24786829
22 Ho EA Osooly M Strutt D Masin D Yang Y Yan H Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model J Pharm Sci 2013 102 227 36 23132529
23 Ngoune R Peters A von Elverfeldt D Winkler K Putz G Accumulating nanoparticles by EPR: A route of no return J Control Release 2016 238 58 70 27448444
24 Koning GA Morselt HW Kamps JA Scherphof GL Uptake and intracellular processing of PEG-liposomes and PEG-immunoliposomes by kupffer cells in vitro 1 * J Liposome Res 2001 11 195 209 19530933
25 Chou LY Ming K Chan WC Strategies for the intracellular delivery of nanoparticles Chem Soc Rev 2011 40 233 45 20886124
26 Khalil IA Kogure K Akita H Harashima H Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol Rev 2006 58 32 45 16507881
27 Zhou X Huang L DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action Biochim Biophys Acta 1994 1189 195 203 8292625
28 Pattingre S Tassa A Qu X Garuti R Liang XH Mizushima N Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 2005 122 927 39 16179260
29 Campbell PM Der CJ Oncogenic Ras and its role in tumor cell invasion and metastasis Semin Cancer Biol 2004 14 105 14 15018894
30 Laplante M Sabatini DM mTOR signaling in growth control and disease Cell 2012 149 274 93 22500797
31 Viloria-Petit AM Wrana JL The TGFbeta-Par6 polarity pathway: linking the Par complex to EMT and breast cancer progression Cell Cycle 2010 9 623 4 20107326
32 Goldstein NI Prewett M Zuklys K Rockwell P Mendelsohn J Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model Clin Cancer Res 1995 1 1311 8 9815926
33 Kim K Lee S Ryu S Han D Efficient isolation and elution of cellular proteins using aptamer-mediated protein precipitation assay Biochem Biophys Res Commun 2014 448 114 9 24768638
34 Wang J Liu R Liu B Cadmium-containing quantum dots: current perspectives on their application as nanomedicine and toxicity concerns Mini Rev Med Chem 2016 16 905 16 26864550
35 Wang Q Chao YM Multifunctional quantum dots and liposome complexes in drug delivery J Biomed Res 2018 32 91 106 28866655
36 Xu G Zeng S Zhang B Swihart MT Yong KT Prasad PN New generation cadmium-free quantum dots for biophotonics and nanomedicine Chem Rev 2016 116 12234 327 27657177
37 Hong G Dai H In vivo fluorescence imaging in the second near-infrared window using carbon nanotubes Methods Mol Biol 2016 1444 167 81 27283426
38 Allen TM Sapra P Moase E Use of the post-insertion method for the formation of ligand-coupled liposomes Cell Mol Biol Lett 2002 7 889 94 12378272
※ AI-Helper는 부적절한 답변을 할 수 있습니다.